熱門

X

    Backchat

    簡介

    GIST

    主持人:Azam Khan and CM Chan

    Backchat is RTHK Radio 3's week-daily current affairs discussion programme, with expert panels and listener participation. It airs every Monday to Friday from 9.05am - 10am (HKT).
    Have your say by calling us on 233 88 266, find us on Facebook - Backchat on RTHK Radio 3, or email backchat@rthk.hk  

    Listen live on Radio 3's homepage - www.rthk.hk/radio/radio3

    最新

    LATEST
    11/03/2026

    Iran war updates / Hong Kong Science Museum's new exhibits / More snakes spotted in Tseung Kwan O

    On this programme, we looked at the conflict in the Middle East, after US President Donald Trump sent confusing signals hinting that the Iran war could end soon. At the same time, Mr Trump is saying that the US could hit the country “twenty times harder”.

    After the break, a curator from the Hong Kong Science Museum told us more about the three new permanent galleries in the museum that focus on how modern technology, such as AI, robotics, and biotechnology, shapes daily life and future innovations.

    And to wrap it up, a lawmaker and pest control experts gave us some tips on what to do if you see snakes, after some residents in Tseung Kwan O reported a spike in sightings.

    9:05am-9:30am: Iran War updates

    Speakers:

    Jeffrey Sachs, Economist and Professor at Columbia University

    Hussein Askary, Vice-President of the Belt and Road Institute in Sweden

    James Dorsey, Senior Fellow at the S. Rajaratnam School of International Studies, Nanyang Technological University

    9:32am-9:43am: Hong Kong Science Museum's new exhibits

    Speaker: Kenus Yan, Curator (Exhibition Enhancement), Hong Kong Science Museum

    9:43am-10:00am: More snakes spotted in Tseung Kwan O

    Speakers:

    Christine Fong, Lawmaker and Sai Kung District Councillor

    Francis Pazos, Chair of No Bed Bugs HK

    William Sargent, Snake catcher

    11/03/2026 - 足本 Full (HKT 09:05 - 10:00)

    11/03/2026 - Iran war updates: part 1

    11/03/2026 - Iran war updates: part 2

    11/03/2026 - Hong Kong Science Museum's new exhibits

    11/03/2026 - More snakes spotted in Tseung Kwan O

    重溫

    CATCHUP
    02 - 03
    2026
    香港電台第三台
    X

    2025 IMD World Competitiveness Ranking / HKTDC Export confidence index / Dual immunotherapy treatment for liver cancer

    主持人:Azam Khan and CM Chan

    On Thursday’s Backchat, we spoke to experts about Hong Kong's significant improvement in its competitiveness. 
    The city has been named the third-most globally competitive economy in the world, climbing two places from last year, according to the 2025 IMD World Competitiveness Ranking. 
    Chief Executive John Lee hailed the report, saying it highlights Hong Kong's world-class business environment and reflects the positive views of business leaders.
    After the break, we talked to a representative from the Trade Development Council to learn more about its latest Export Confidence Index and 2025 export forecast.
    And finally, we heard from an expert about a dual immunotherapy treatment for liver cancer that has received approval from three major health authorities for global use.
    9:05am-9:30am: 2025 IMD World Competitiveness Ranking
    9:05am-9:30am: Cecilia Lam, Acting Government Economist
    9:05am-9:23am: Ho Lok Sang, Adjunct Professor at the Pan Sutong Shanghai-Hong Kong Economic Policy Research Institute, Lingnan University
    9:12am-9:30am: Robert Lee, Financial Services Sector Lawmaker 
    9:32am-9:48am: HKTDC Export confidence index
    9:32am-9:48am: Irina Fan, Director of Research at the Hong Kong Trade Development Council (HKTDC)
    9:48am-10:00am:  Dual immunotherapy treatment for liver cancer
    9:48am-10:00am: Thomas Yau Chung-cheung, Clinical Associate Professor at Li Ka Shing Faculty of Medicine, The University of Hong Kong

    香港電台第三台

    19/06/2025 - 足本 Full (HKT 09:05 - 10:00)

    19/06/2025 - 2025 IMD World Competitiveness Ranking

    19/06/2025 - HKTDC Export confidence index

    19/06/2025 - Dual immunotherapy treatment for liver cancer